Genetic polymorphisms in DNA repair genes as modulators of hodgkin disease risk

Cancer

Volumn 115, Issue 8, 2009, Pages 1651-1659

  El Zein, Randa ^a,b   Monroy, Claudia M ^b   Etzel, Carol J ^b   Cortes, Andrea C ^b   Xing, Yun ^b   Collier, Amanda L ^b   Strom, Sara S ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

DNA repair; Genetic polymorphisms; Hodgkin disease; Susceptibility

Indexed keywords

XERODERMA PIGMENTOSUM GROUP C PROTEIN; XERODERMA PIGMENTOSUM GROUP D PROTEIN; XRCC1 PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; DNA REPAIR; EXCISION REPAIR; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; DNA REPAIR; DNA-BINDING PROTEINS; ENDONUCLEASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; POLYMORPHISM, GENETIC; RISK FACTORS; TRANSCRIPTION FACTORS; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 65249178990     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24205     Document Type: Article

References (61)

1. American Cancer Society. Cancer Facts and Figures 2008, American Cancer Society. Atlanta, GA: American Cancer Society; 2008.
2. Spitz MR, Bondy ML. Genetic susceptibility to cancer. Cancer. 1993;72:991-995.
3. Wei Q, Cheng L, Hong WK, Spitz MR. Reduced DNA repair capacity in lung cancer patients. Cancer Res. 1996;56: 4103-4107.
4. Kyrtopoulos SA. Variability in DNA repair and individual susceptibility to genotoxins. Clin Chem. 1995;41:1848-1853.
5. Wei Q, Gu J, Cheng L, et al. Benzo(a)pyrene diol epoxide- induced chromosomal aberrations and risk of lung cancer. Cancer Res. 1996;56:3975-3979.
6. Spitz MR, McPherson RS, Jiang H, et al. Correlates of mutagen sensitivity in patients with upper aerodigestive tract cancer. Cancer Epidemiol Biomarkers Prev. 1997;6:687-692.
7. Okuyama S. Evolution of Hodgkin's disease. Med Hypotheses. 1996;47:199-213.
8. Helzlsouer KJ, Harris EL, Parshad R, Fogel S, Bigbee WL, Sanford KK. Familial clustering of breast cancer: possible interactions between DNA repair exposure on the development of breast cancer. Int J Cancer. 1995;64:14-17.
9. Knight R, Parshad R, Price F, Tarone R, Sanford K. X-ray induced chromatid damage in relation to DNA repair and cancer incidence in family members. Int J Cancer. 1993;54:589-593.
10. Shen MR, Jones IM, Mohrenweiser H. Non-conservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res. 1998;58:604-608.
11. Berwick M, Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst. 2000;92:874-897.
12. Dybdahl M, Vogel U, Frentz G, Wallin H, Nexo BA. Polymorphisms in the DNA repair gene XPD: correlations with risk and age at onset of basal cell carcinoma. Cancer Epidemiol Biomarkers Prev. 1999;8:77-81.
13. Au WW, Navasumrit P, Ruchirawat M. Use of biomarkers to characterize functions of polymorphic DNA repair genotypes. Int J Hyg Environ Health. 2004;207:301-313.
14. Abraham J, Earl HM, Pharoah PD, Caldas C. Pharmacoge- netics of cancer chemotherapy. Biochim Biophys Acta. 2006; 1766:168-183.
15. Manuguerra M, Saletta F, Karagas MR, et al. XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review. Am J Epidemiol. 2006;15:297-302.
16. Ribas G, Gonzalez-Neira A, Salas A, et al. Evaluating Hap- Map SNP data transferability in a large-scale genotyping project involving 175 cancer-associated genes. Hum Genet. 2006;118:669-679.
17. Shen H, Sturgis EM, Khan SG, et al. An intronic Poly(AT) polymorphism of the DNA repair gene XPC and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Res. 2001;61:3321-3325.
18. Sanyal S, Festa F, Sakano S, et al. Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 2004;25:729-734.
19. Vogel U, Overvad K, Wallin H, et al. Combinations of polymorphisms in XPD, XPC and XPA in relation to risk of lung cancer. Cancer Lett 2005;222:67-74.
20. Smedby KE, Lindgren CM, Hjalgrim H, et al. Variation in DNA repair genes ERCC2, XRCC1, and XRCC3 and risk of follicular lymphoma. Cancer Epidemiol Biomarkers Prev. 2006;15:258-265.
21. Shen M, Purdue MP, Kricker A, et al. Polymorphisms in DNA repair genes and risk of non-Hodgkin's lymphoma in New South Wales, Australia. Haematologica. 2007;92:1180-1185.
22. Hayden PJ, Tewari P, Morris DW, et al. Variation in DNA repair genes XRCC3, XRCC4, XRCC5 and susceptibility to myeloma. Hum Mol Genet. 2007;16:3117-3127.
23. Deligezer U, Akisik EE, Dalay N. Lack of association of XRCC1 codon 399Gln polymorphism with chronic myelogenous leukemia. Anticancer Res. 2007;27:2453-2456.
24. Song B, Zhu JY, Liu J, et al. Association of gene polymorphisms in the DNA repair gene XPD with risk of non- Hodgkin's lymphoma. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008;16:97-100.
25. Mertens AC, Mitby PA, Radloff G, et al. XRCC1 and glutathione-S- transferase gene polymorphisms and susceptibility to radiotherapy-related malignancies in survivors of Hodgkin disease. Cancer. 2004;101:1463-1472.
26. Jeon HS, Kim KM, Park SH, et al. Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer. Carcinogenesis. 2003;24:1677-1681.
27. Ritchie MD, Hahn LW, Roodi N, et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet. 2001;69:138-147.
28. Moore JH, Gilbert JC, Tsai CT, et al. A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. J Theor Biol. 2006;241:252-261.
29. Popanda O, Schattenberg T, Phong CT, et al. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis. 2004;25:2433-2441.
30. Friedberg EC. How nucleotide excision repair protects against cancer. Nat Rev Cancer. 2001;1:22-33.
31. Zijno A, Verdina A, Galati R, et al. Influence of DNA repair polymorphisms on biomarkers of genotoxic damage in peripheral lymphocytes of healthy subjects. Mutat Res. 2006;600:184-192.
32. Matullo G, Palli D, Peluso M, et al. XRCC1, XRCC3, XPD gene polymorphisms, smoking and 32P-DNA adducts in a sample of healthy subjects. Carcinogenesis. 2001;22:1437-1445.
33. Palli D, Russo A, Masala G, et al. DNA adduct levels and DNA repair polymorphisms in traffic-exposed workers and a general population sample. Int J Cancer. 2001;94:121-127.
34. Chatterjee N, Kalaylioglu Z, Moslehi R, Peters U, Wacholder S. Powerful multilocus tests of genetic association in the presence of gene-gene and gene-environment interactions. Am J Hum Genet. 2006;79:1002-1016.
35. Hill DA, Wang SS, Cerhan JR, et al. Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes. Blood. 2006;108:3161- 3167.
36. Shen M, Zheng T, Lan Q, et al. Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut. Hum Genet. 2006;119:659-668.
37. Wang SS, Davis S, Cerhan JR, et al. Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma. arcinogenesis. 2006;27:1828-1834.
38. Caldecott KW, Aoufouchi S, Johnson P, Shall S. XRCC1 olypeptide interacts with DNA polymerase beta and possibly poly (ADP-ribose) polymerase, and DNA ligase III is a novel molecular' nick-sensor' in vitro. Nucleic Acids Res. 1996;24:4387-4394.
39. Kubota Y, Nash RA, Klungland A, Schar P, Barnes DE, Lindahl T. Reconstitution of DNA base excision-repair with purified human proteins: interaction between DNA polymerase beta and the XRCC1 protein. EMBO J. 1996;15:6662-6670.
40. Marintchev A, Mullen MA, Maciejewski MW, Pan B, Gryk MR, Mullen GP. Solution structure of the single- strand break repair protein XRCC1 N-terminal domain. Nat Struct Biol. 1999;6:884-893.
41. Lunn RM, Langlois RG, Hsieh LL, Thompson CL, Bell DA. XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res. 1999;59:2557-2561.
42. Abdel-Rahman SZ, El-Zein RA. The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specific nitrosamine NNK. Cancer Lett. 2000;159:63-71.
43. Relton CL, Daniel CP, Fisher A, Chase DS, Burn J, Tawn EJ. Polymorphisms of the DNA repair gene XRCC1 and the frequency of somatic mutations at the glycophorin A locus in newborns. Mutat Res. 2002;502:61-68.
44. Dulic A, Bates PA, Zhang X, et al. BRCT domain interactions in the heterodimeric DNA repair protein XRCC1- DNA ligase III. Biochemistry. 2001;40:5906-5913.
45. Taylor RM, Thistlethwaite A, Caldecott KW. Central role for the XRCC1 BRCT I domain in mammalian DNA single-strand break repair. Mol Cell Biol. 2002;22:2556-2563.
46. Kang SY, Lee KG, Lee W, et al. Polymorphisms in the DNA repair gene XRCC1 associated with basal cell carcinoma and squamous cell carcinoma of the skin in a Korean population. Cancer Sci. 2007;98:716-720.
47. Berndt SI, Huang WY, Fallin MD, et al. Genetic variation in base excision repair genes and the prevalence of advanced colorectal adenoma. Cancer Res. 2007;67:1395-1404.
48. Duarte MC, Colombo J, Rossit AR, et al. Polymorphisms of DNA repair genes XRCC1 and XRCC3, interaction with environmental exposure and risk of chronic gastritis and gastric cancer. World J Gastroenterol. 2005;11:6593-6600.
49. Stern MC, Conway K, Li Y, Mistry K, Taylor JA. DNA repair gene polymorphisms and probability of p53 mutation in bladder cancer. Mol Carcinog. 2006;45:715-719.
50. Feng L, Lin T, Uranishi H, Gu W, Xu Y. Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity. Mol Cell Biol. 2005;25:5389-5395.
51. Feuerborn A, Moritz C, Von Bonin F, et al. Dysfunctional p53 deletion mutants in cell lines derived from Hodgkin's lymphoma. Leuk Lymphoma. 2006;47:1932-1940.
52. Kim LH, Peh SC, Poppema S. Expression of retinoblas- toma protein and P16 proteins in classic Hodgkin lym- phoma: relationship with expression of p53 and presence of Epstein-Barr virus in the regulation of cell growth and death. Hum Pathol. 2006;37:92-100.
53. Ratnasinghe LD, Abnet C, Qiao YL, et al. Polymorphisms of XRCC1 and risk of esophageal and gastric cardia cancer. Cancer Lett. 2004;216:157-164.
54. Duan Z, Shen H, Lee JE, et al. DNA repair gene XRCC3 241Met variant is not associated with risk of cutaneous malignant melanoma. Cancer Epidemiol Biomarkers Prev. 2002;11:1142-1143.
55. Shen H, Wang X, Hu Z, et al. Polymorphisms of DNA repair gene XRCC3 Thr241Met and risk of gastric cancer in a Chinese population. Cancer Lett. 2004;206:51-58.
56. Marin MS, Lopez-Cima MF, Garcia-Castro L, Pascual T, Marron MG, Tardon A. Poly (AT) polymorphism in intron 11 of the XPC DNA repair gene enhances the risk of lung cancer. Cancer Epidemiol Biomarkers Prev. 2004;13: 1788-1793.
57. Casson AG, Zheng Z, Evans SC, Veugelers PJ, Porter GA, Guernsey DL. Polymorphisms in DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma. Carcinogenesis. 2005;26:1536-1541.
58. Lopez-Cima MF, Gonzalez-Arriaga P, Garcia-Castro L, et al. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain. BMC Cancer. 2007;7:162.
59. De Ruyck K, Szaumkessel M, De Rudder I, et al. Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk. Mutat Res. 2007;631:101-110.
60. Spitz MR, Hong WK, Amos CI, et al. A risk model for prediction of lung cancer. J Natl Cancer Inst. 2007;99:715-726.
61. Wu X, Lin J, Etzel CJ, et al. Interplay between mutagen sensitivity and epidemiological factors in modulating lung cancer risk. Int J Cancer. 2007;120:2687-2695.